Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cavalli, A."'
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine, Vol 8 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated coronavirus disease 2019 (COVID-19) pandemic has been the subject of a large number of studies in recent times. Here, starting from the evidence that in Italy, the areas with the
Autor:
Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Coronavirus disease 2019 (COVID-19) is a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 result in acute respiratory distress syndrome and death. A detrimental, hyper-inflammatory immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765843a161afba785fb5fccbee22fb6b
Autor:
Antonio Vitale, Giulio Cavalli, Piero Ruscitti, Jurgen Sota, Serena Colafrancesco, Roberta Priori, Guido Valesini, Lorenza Maria Argolini, Elena Baldissera, Elena Bartoloni, Daniele Cammelli, Giovanni Canestrari, Elena Cavallaro, Maria Grazia Massaro, Paola Cipriani, Ginevra De Marchi, Salvatore De Vita, Giacomo Emmi, Micol Frassi, Roberto Gerli, Elisa Gremese, Florenzo Iannone, Marco Fornaro, Anna Paladini, Giuseppe Lopalco, Raffaele Manna, Alessandro Mathieu, Carlomaurizio Montecucco, Marta Mosca, Ilaria Piazza, Matteo Piga, Irene Pontikaki, Micol Romano, Silvia Rossi, Maurizio Rossini, Elena Silvestri, Chiara Stagnaro, Rosaria Talarico, Bruno Frediani, Angela Tincani, Ombretta Viapiana, Gianfranco Vitiello, Paola Galozzi, Paolo Sfriso, Carla Gaggiano, Salvatore Grosso, Donato Rigante, Lorenzo Dagna, Roberto Giacomelli, Luca Cantarini
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine, Vol 7 (2020)
Background: Aim of this study was to search for any difference in the outcome of patients with adult onset Still's disease (AOSD) treated with anakinra (ANK) in relation with the interval between disease onset and the start of anti-interleukin(IL)-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d6d49d4a1e1236726b26738e4dfe87
http://hdl.handle.net/11573/1555830
http://hdl.handle.net/11573/1555830
Autor:
Borna Relja, Paola Cavalli, Aleksander J Nowak, Andrea Janicova, Claudia Neunaber, Ildiko Rita Dunay, Florian Haag, Ingo Marzi, Baolin Xu, Ramona Sturm, Alejandra P. Garza
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
BackgroundExcessive alcohol intake is associated with adverse immune response-related effects, however, acute and chronic abuse differently modulate monocyte activation. In this study, we have evaluated the phenotypic and functional changes of monocy
Autor:
Giulio Cavalli, Charles A. Dinarello
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology, 9
Frontiers in Pharmacology
Frontiers in Pharmacology, 9
Frontiers in Pharmacology
Contains fulltext : 200576.pdf (Publisher’s version ) (Open Access) Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1alpha and IL-1beta) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondar
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Myocarditis is defined by WHO as an inflammatory disease affecting the myocardium, diagnosed by endomyocardial biopsy (EMB) using established histological, immunological, and immunohistochemical criteria; it may be idiopathic, infectious, or autoimmu
Autor:
Ilaria Del Giudice, Sara Raponi, Irene Della Starza, Maria Stefania De Propris, Marzia Cavalli, Lucia Anna De Novi, Luca Vincenzo Cappelli, Caterina Ilari, Luciana Cafforio, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
In chronic lymphocytic leukemia (CLL), there is a growing interest for minimal residual disease (MRD) monitoring, due to the availability of drug combinations capable of unprecedented complete clinical responses. The standardized and most commonly ap
Autor:
Marco Vaira, Alice Borsano, Rita Spagnolo, Monica Argenziano, M. Robella, Michele De Simone, Sergio Gentilli, Roberta Cavalli
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology, Vol 10 (2019)
Background: Peritoneal carcinomatosis is a common metastatic pattern in ovarian, gastric, colorectal, and appendiceal cancer; systemic chemotherapy is the current standard of care for peritoneal metastatic disease; however, in a subset of patients it
Autor:
Irene Della Starza, Sabina Chiaretti, Maria S. De Propris, Loredana Elia, Marzia Cavalli, Lucia A. De Novi, Roberta Soscia, Monica Messina, Antonella Vitale, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Introduction: Acute lymphoblastic leukemia (ALL) is the first neoplasm where the assessment of early response to therapy by minimal residual disease (MRD) monitoring has proven to be a fundamental tool to guide therapeutic choices. The most standardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58ecd38e2b659b4c8e6d1f6ee372c28d
http://hdl.handle.net/11573/1414764
http://hdl.handle.net/11573/1414764